Neomend

About:

Neomend is a biomedical device company engaged in the development and commercialization of surgical wound healing products.

Website: http://www.neomend.com

Top Investors: Vivo Capital, Novo Ventures, Clarus Ventures, Sanderling Ventures, Prospect Venture Partners

Description:

Neomend is a biomedical device company that engages in the development and commercialization of surgical wound healing products. Its platform technology, Pro/PEG, is a bioadhesive polymer hydrogel. NeoMend engages in the commercialization of the combination wound sealant and adhesion barrier product that can be delivered during minimally invasive/laparoscopic procedures.

Total Funding Amount:

$61.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Irvine, California, United States

Founded Date:

1999-01-01

Contact Email:

customerservice(AT)neomend.com

Founders:

Thomas Wehman

Number of Employees:

51-100

Last Funding Date:

2011-08-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai